Calcium gluceptate Disease Interactions
There are 4 disease interactions with calcium gluceptate.
Calcium salts (applies to calcium gluceptate) calcium- phosphate calcifications
Major Potential Hazard, High plausibility. Applicable conditions: Phosphate Imbalance
Elevated serum concentrations of calcium and phosphate can exceed the solubility level and result in calcium- phosphate precipitates that deposit in vascular and renal systems as well as other soft tissues of the body. Therapy with calcium should be administered with extreme caution in patients with hyperphosphatemia (hypoparathyroidism or severe renal impairment). Administration of oral calcium acetate or calcium carbonate, in addition to providing calcium, complexes phosphates within the GI tract. These complexes are eliminated in the feces. Clinical monitoring of serum calcium and phosphate concentrations is necessary.
References (2)
- "Product Information. Posture (calcium phosphate, tribasic)." Whitehall-Robbins
- (2001) "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation
Calcium salts (applies to calcium gluceptate) cardiac contraction/conduction
Major Potential Hazard, High plausibility. Applicable conditions: Arrhythmias
Calcium is involved in cardiac muscle contraction and electrical impulse conduction. Therapy with calcium salt formulations (particularly IV) should be administered cautiously to patients with cardiac disease. Patients receiving cardiac glycosides and concomitant IV calcium may experience arrhythmias. Therapy with IV calcium should be administered slowly and at reduced dosages in patients with cardiac disease.
References (2)
- "Product Information. Posture (calcium phosphate, tribasic)." Whitehall-Robbins
- (2001) "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation
Calcium salts (applies to calcium gluceptate) renal dysfunction
Major Potential Hazard, High plausibility.
Absorption of oral calcium formulations may be altered and elimination of calcium by the kidney decreased with renal impairment. Hyperphosphatemia occurs during renal failure. Calcium acetate or calcium carbonate, in addition to providing calcium, complexes phosphates within the GI tract. Calcium carbonate can partially correct metabolic acidosis associated with chronic renal failure. Clinical monitoring of renal function and serum calcium and phosphate concentrations is necessary.
References (2)
- "Product Information. Posture (calcium phosphate, tribasic)." Whitehall-Robbins
- (2001) "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation
Calcium salts (applies to calcium gluceptate) sarcoidosis
Major Potential Hazard, High plausibility.
Hypercalciuria, with or without hypercalcemia, may occasionally occur in patients with sarcoidosis. Elevated calcium levels may result from increased intestinal absorption of calcium, which is related to the extrarenal production of vitamin D by mononuclear phagocytes present within the sarcoid granuloma. Therapy with calcium salts should be administered cautiously and only if necessary in patients with sarcoidosis.
References (3)
- "Product Information. Posture (calcium phosphate, tribasic)." Whitehall-Robbins
- (2001) "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation
- Braunwald E, Hauser SL, Kasper DL, Fauci AS, Isselbacher KJ, Longo DL, Martin JB, eds., Wilson JD (1998) "Harrison's Principles of Internal Medicine." New York, NY: McGraw-Hill Health Professionals Division
Switch to consumer interaction data
Calcium gluceptate drug interactions
There are 36 drug interactions with calcium gluceptate.
More about calcium gluceptate
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: minerals and electrolytes
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Drisdol
Drisdol is used for familial hypophosphatemia, hypocalcemia, hypoparathyroidism, hypophosphatemia ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Tums Regular Strength
Tums Regular Strength is used for duodenal ulcer, erosive esophagitis, GERD, indigestion, stomach ulcer
Rocaltrol
Rocaltrol is used for hypocalcemia, hypoparathyroidism, renal osteodystrophy, rickets, secondary ...
Rayaldee
Rayaldee is used for hyperparathyroidism secondary to renal impairment
Calcium gluconate
Calcium gluconate is used to prevent and to treat calcium deficiencies. Includes calcium gluconate ...
Calcium carbonate
Calcium carbonate systemic is used for duodenal ulcer, erosive esophagitis, GERD, hypocalcemia ...
Calcitriol
Calcitriol systemic is used for hypocalcemia, hypoparathyroidism, renal osteodystrophy, rickets ...
Ergocalciferol
Ergocalciferol systemic is used for familial hypophosphatemia, hypocalcemia, hypoparathyroidism ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.